Clinical trial
To Observe the Effectiveness and Safety of Anti-TNFs in Patients With Moderate to Severe Psoriasis
NCT01126619 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Observe the Effectiveness and Safety of Anti-TNFs in Patients With Moderate to Severe Psoriasis
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- September 30, 2011
- Enrollment
- 103 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.